Berlin, 15-19 April 2008
Watch Press Conferences from EBCC 6
Dr. Sibylle Loibl: Pregnant patients lose out in breast cancer treatment.
View slides
Dr. David Martinez-Cecila: MRI before surgery leads to better-adapted treatment.
View slides
Dr. Evandro de Azambuja: Obese women disadvantaged in both treatment and diagnosis.
View slides
Dr. Elisabetta Rapiti: Obese women disadvantaged in both treatment and diagnosis.
View slides
Dr. Alain Monnier: New research shows no link between aromatase inhibitors and cardiovascular problems.
View slides
Professor Gunter von Minckwitz: New chemotherapy combo produces side effects, but no extra efficacy, in early breast cancer patients.
View slides
Dr. Angel Rodriguez: New drug shrinks breast cancer tumours significantly in just six weeks; research shows that cancer stem cells can be therapeutic target.
View slides
Mr. Jacques Fracheboud: Is an annual mammogram better than a three-yearly one, and should women be screened up to the age of 75?
Professor Roger Blamey: Is an annual mammogram better than a three-yearly one, and should women be screened up to the age of 75?
View slides
Ms Jill Hervik: Acupuncture relieves hot flushes in breast cancer patients taking tamoxifen.
View slides
Professor Michael Untch: Combining trastuzumab with neoadjuvant chemotherapy before surgery; surprising new data on safety and efficacy.
View slides
ECCO and ESMO join forces: Michel Ballieu, CEO of ECCO, and Åge Schultz, Executive Director of ESMO, discuss the new collaboration.
Watch further interviews here.
For the official EBCC 6 press releases please visit ECCO.